{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:10:06Z","timestamp":1789625406781,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Not applicable","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The COVID-19 pandemic has caused major disruption to healthcare services globally and has impacted on tuberculosis (TB) patients and TB diagnosis and treatment services both in low- and high-income countries. We therefore explored the perspectives of members of regional and international TB control and research networks to further understand TB service disruptions and compared the experiences of members from West African and European countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional, explorative descriptive study was conducted from May to July 2020 using an open online survey with target respondents from both West African and European countries. The survey comprised discrete questions exploring challenges faced with TB screening, diagnosis, treatment, prevention, and changes implemented. Additionally, respondents were asked to provide recommendations for remedial actions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We analysed responses from 124 respondents based in 29 countries located in Europe and West Africa. About half of the respondents reported challenges in delivering routine TB services during the COVID-19 pandemic, with over one third reporting having some form of guidance issued regarding maintaining delivery of routine TB services. Respondents emphasised the need for strengthening TB services especially in light of COVID-19 pandemic. Considerable similarities were found between the challenges experienced by TB professionals in both West African and European settings. Responses also highlighted the hidden challenges faced in some countries prior to the COVID-19 pandemic, especially in some West African settings where staff shortages and laboratory issues predated COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TB control and research professionals in West African and European settings experienced similar challenges to the delivery of TB diagnosis and treatment services due to the COVID-19 pandemic, and highlighted the need for clear communication of guidelines, prioritisation of routine TB service delivery, ongoing health education, and possible integration of TB and COVID-19 services to ensure that TB services are more resilient against the impact of the pandemic.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12913-021-06852-z","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T08:03:05Z","timestamp":1628755385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploring the perspectives of members of international tuberculosis control and research networks on the impact of COVID-19 on tuberculosis services: a cross sectional survey"],"prefix":"10.1186","volume":"21","author":[{"given":"Oluwatosin","family":"Nkereuwem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin","family":"Nkereuwem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Fiogbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eno E.","family":"Usoroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdou K.","family":"Sillah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumuyiwa","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulie","family":"Badjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyin","family":"Togun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"6852_CR1","unstructured":"World Health Organization: Rolling updates on coronavirus disease (COVID-19).\u00a0 WHO: Geneva. (2020) Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/events-as-they-happen (cited 15 Oct\u00a02020)"},{"issue":"2","key":"6852_CR2","doi-asserted-by":"publisher","first-page":"e0244936","DOI":"10.1371\/journal.pone.0244936","volume":"16","author":"MS Khan","year":"2021","unstructured":"Khan MS, Rego S, Rajal JB, Bond V, Fatima RK, Isani AK, Sutherland J, Kranzer K. Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries. PloS one. 2021;16(2):e0244936.","journal-title":"PloS one"},{"key":"6852_CR3","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2020. Geneva: World Health Organization (WHO); 2020."},{"issue":"9","key":"6852_CR4","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1016\/S2214-109X(20)30288-6","volume":"8","author":"AB Hogan","year":"2020","unstructured":"Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, Hamlet A, Smith JA, Winskill P, Verity R, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Global Health. 2020;8(9):e1132\u201341.","journal-title":"Lancet Global Health"},{"issue":"1","key":"6852_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pulmoe.2020.05.013","volume":"27","author":"D Buonsenso","year":"2021","unstructured":"Buonsenso D, Iodice F, Sorba Biala J, Goletti D. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology. 2021;27(1):67\u20139.","journal-title":"Pulmonology"},{"key":"6852_CR6","doi-asserted-by":"crossref","unstructured":"Nikolayevskyy V, Holicka Y, van Soolingen D, van der Werf MJ, K\u00f6dm\u00f6n C, Surkova E, Hillemann D, Groenheit R, Cirillo D. Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe. Eur Respir J. 2021;57(1).","DOI":"10.1183\/13993003.03890-2020"},{"key":"6852_CR7","volume-title":"Resolution WHA67.1. Global strategy and targets for tuberculosis prevention, care and control after 2015","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Resolution WHA67.1. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization; 2014."},{"key":"6852_CR8","doi-asserted-by":"crossref","unstructured":"McQuaid CF, McCreesh N, Read JM, Sumner T, Houben R, White RG, Harris RC: The potential impact of COVID-19-related disruption on tuberculosis burden. Eur Respir J\u00a02020;56(2).","DOI":"10.1183\/13993003.01718-2020"},{"issue":"1","key":"6852_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12941-020-00363-1","volume":"19","author":"T Togun","year":"2020","unstructured":"Togun T, Kampmann B, Stoker NG, Lipman M. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob. 2020;19(1):21.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"6852_CR10","doi-asserted-by":"crossref","unstructured":"Nkereuwem E, Kampmann B, Togun T. The need to prioritise childhood tuberculosis case detection. Lancet. 2021;397(0281):1248-9.","DOI":"10.1016\/S0140-6736(21)00672-3"},{"key":"6852_CR11","unstructured":"Maintaining essential health services: operational guidance for the COVID-19 context [https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-essential-health-services-2020.1]"},{"issue":"9","key":"6852_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2352-4642(20)30177-2","volume":"4","author":"F Gotzinger","year":"2020","unstructured":"Gotzinger F, Santiago-Garcia B, Noguera-Julian A, Lanaspa M, Lancella L, Calo Carducci FI, Gabrovska N, Velizarova S, Prunk P, Osterman V, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653\u201361.","journal-title":"Lancet Child Adolesc Health"},{"key":"6852_CR13","unstructured":"The UK National Health Service (NHS) Health Research Authority: Governance Arrangements for Research Ethics Committees: 2020 edition.\u00a0\u00a02020. Available from: https:\/\/s3.eu-west-2.amazonaws.com\/www.hra.nhs.uk\/media\/documents\/GAfREC_Final_v2.0_26.03.2020.pdf (cited 25 April 2021)."},{"issue":"2","key":"6852_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"6852_CR15","unstructured":"Notes for the clinic - a patient with tuberculosis and COVID-19 [https:\/\/www.spfs.sk\/oznamy\/404-pozn%C3%A1mky-pre-klinika-pacient-s-tuberkul%C3%B3zou-a-covid-19]"},{"key":"6852_CR16","unstructured":"Managing TB during the COVID-19 Pandemic\u00a0[https:\/\/www.rcn.org.uk\/news-and-events\/blogs\/managing-tb-during-the-covid-19-pandemic]"},{"issue":"2","key":"6852_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1183\/09031936.00009212","volume":"40","author":"G Sotgiu","year":"2012","unstructured":"Sotgiu G, D\u2019Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, et al. Availability of anti-tuberculosis drugs in Europe. Eur Respir J. 2012;40(2):500\u20133.","journal-title":"Eur Respir J"},{"issue":"5","key":"6852_CR18","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1016\/S2352-3018(20)30109-0","volume":"7","author":"P Adepoju","year":"2020","unstructured":"Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. Lancet HIV. 2020;7(5):e319\u201320.","journal-title":"Lancet HIV"},{"issue":"9","key":"6852_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S2213-2600(20)30311-8","volume":"8","author":"C Keene","year":"2020","unstructured":"Keene C, Mohr-Holland E, Cassidy T, Scott V, Nelson A, Furin J, Trivi\u00f1o-Duran L. How COVID-19 could benefit tuberculosis and HIV services in South Africa. Lancet Respir Med. 2020;8(9):844\u20136.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"6852_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.7196\/SAMJ.2020.v110i12.15126","volume":"110","author":"M Loveday","year":"2020","unstructured":"Loveday M, Cox H, Evans D, Furin J, Ndjeka N, Osman M, Naidoo For The National Tb Think Tank \u2018Optimising Tb Treatment Outcomes\u2019 Task Team K. Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa. S Afr Med J. 2020;110(12):1160\u20137.","journal-title":"S Afr Med J"},{"key":"6852_CR21","doi-asserted-by":"crossref","unstructured":"Ola BA, Nkereuwem E, Oriero EC, Okomo U, Afolabi MO, Togun T. COVID-19 in Nigeria: immplications for management of related co-morbidities, prevalent public health challenges, and future epidemic preparedness. Proc Nigerian Acad Sci. 2020;13(1s).","DOI":"10.57046\/BWWL7233"},{"key":"6852_CR22","doi-asserted-by":"publisher","first-page":"103181","DOI":"10.1016\/j.ebiom.2020.103181","volume":"63","author":"T Togun","year":"2021","unstructured":"Togun T. Childhood tuberculosis in high burden settings. EBioMedicine. 2021;63:103181.","journal-title":"EBioMedicine"},{"key":"6852_CR23","doi-asserted-by":"crossref","unstructured":"Alene KA, Wangdi K, Clements ACA. Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview. Trop Med Infect Dis. 2020;5(3):123.","DOI":"10.3390\/tropicalmed5030123"},{"issue":"6","key":"6852_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.arcmed.2020.04.017","volume":"51","author":"F Hellmann","year":"2020","unstructured":"Hellmann F, Williams-Jones B, Garrafa V. COVID-19 and Moral Imperialism in Multinational Clinical Research. Arch Med Res. 2020;51(6):572\u20133.","journal-title":"Arch Med Res"},{"key":"6852_CR25","doi-asserted-by":"crossref","unstructured":"B\u00fcy\u00fcm AM, Kenney C, Koris A, Mkumba L, Raveendran Y. Decolonising global health: if not now, when? BMJ Glob Health. 2020;5(8).","DOI":"10.1136\/bmjgh-2020-003394"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06852-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-021-06852-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06852-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T06:00:55Z","timestamp":1673071255000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-021-06852-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6852"],"URL":"https:\/\/doi.org\/10.1186\/s12913-021-06852-z","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"22 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey was carried out in accordance with research ethics and governance guideline of the UK National Health Services (NHS) Health Research Authority. Research ethics committee review is not required for research involving healthcare staff recruited as research participants by virtue of their professional role (<i>Governance Arrangements for Research Ethics Committees, paragraph 2.3.14<\/i>). We therefore did not apply for a formal ethical approval. The survey was circulated only to the members of the respective international TB control and research networks using their email addresses and encrypted WhatsApp chat groups. The survey had an introductory text stating its purpose and that the survey was completely anonymous, and informed consent was implied by respondents agreeing to participate and completing the survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"798"}}